Skip to main content

Cornell University

Zepbound outduels Wegovy in weight-loss clinical trial

May 14, 2025

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.